267 Claudin-7 (Cldn-7), a member of the tight junction protein family, is closely related to inflammation and tumor development, and Cldn-7 deficiency can significantly upregulate the expression of -catenin and its downstream target genes c-myc and cyclin D1 by promoting aberrant activation of the Wnt/-catenin pathway, which in turn leads to abnormal cell proliferation and tumorigenesis
Why isn't the body shooting my leptin levels up to try to fight that GLP-1 signal, to say no, no, you're not taking in enough calories, we need more
This indicates that oral GLP-1 medications can be a viable option for individuals struggling with obesity
Thats when she noticed a lot of the people who were on ventilators or dying had something in common: obesity
The time to plan is now As new uses for GLP-1 medications arise, we believe plan sponsors should start preparing now for increased demand and develop a program approach that balances appropriate access with maintaining benefit affordability